Advertisement

Topics

Baro-Therapies, Inc. Company Profile

18:03 EDT 23rd September 2018 | BioPortfolio


News Articles [220 Associated News Articles listed on BioPortfolio]

Opportunity remains in oncology for gene therapies, says GlobalData

Small pharma leads the way in cancer gene therapies Gene therapies combine reduced treatment duration with a higher chance of...Read More... The post Opportunity remains in oncology for gene therapies...

Gene Therapies are Proving their Worth, but with Million Dollar Price Tags, it’s not Clear Who should Pay for Them

Sterghios Moschos, Associate Professor in Cellular and Molecular Sciences at Northumbria University discusses the benefits of gene therapies and the financial implications of treatments. If you were b...

In a bid to promote stem cell therapies, health officials open a new door for promising contenders

At a time when there’s significant hype around stem cell therapies, the FDA is moving to promote therapies that show the greatest potential.

FDA Sets Path for Stem Cell Therapies

(CNN) – Just months after the US Food and Drug Administration announced efforts to crack down on stem cell clinics touting unapproved therapies, the agency now plans to help expedite the develop...

Nonstatin therapies aid in additional LDL lowering

LAS VEGAS — Nonstatin therapies such as ezetimibe and PCSK9 inhibitors reduce the risk for CVD in patients who require additional LDL lowering, according to a presentation at the National Lipid Asso...

ACT resistance will spur the uptake of novel malaria therapies

Today, artemisinin-based combination therapies (ACTs) are the first-line drugs used to treat malaria across Asia and Africa, the areas of...Read More... The post ACT resistance will spur the uptake of...

An overview of the gene therapies in development for CVMD

Gene therapies have been a point of discussion during the last several years as a potential curative option for a...Read More... The post An overview of the gene therapies in development for CVMD appe...

SMC endorses five new therapies for NHS Scotland

Scottish cost regulators have approved funding for five new therapies on the NHS, offering new treatment options for a range of conditions.

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Hepsera [Excella GmbH]

These highlights do not include all the information needed to use HEPSERA safely and effectively. See full prescribing information for HEPSERA. HEPSERA (adefovir dipivoxil) tablet for oral use Initia...

Hepsera [Gilead Sciences, Inc.]

These highlights do not include all the information needed to use HEPSERA safely and effectively. See full prescribing information for HEPSERA. HEPSERA (adefovir dipivoxil) tablet for oral use Initia...

Olay total effects uv moisturizer [Procter & Gamble Manufacturing Company]

OLAY total effects

PubMed Articles [531 Associated PubMed Articles listed on BioPortfolio]

Emerging therapies for mitochondrial diseases.

For the vast majority of patients with mitochondrial diseases, only supportive and symptomatic therapies are available. However, in the last decade, due to extraordinary advances in defining the cause...

Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies.

Mind-body therapies: Connecting the parts and embracing diversity.

The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: A systematic review and best-evidence synthesis.

Acne vulgaris is a multifaceted skin disorder, affecting more than 85% of young individuals worldwide. Pharmacological therapy is not always desirable because of the development of antibiotic resistan...

Complementary and integrative therapies for psoriasis: Looking forward.

Despite the great advances in our understanding of disease pathogenesis and a rich variety of therapeutic options, including the availability of newer biologic agents, there is still no cure for psori...

Clinical Trials [1607 Associated Clinical Trials listed on BioPortfolio]

Low Intensity Exercise in Different Normobaric/Hypobaric Normoxic/Hypoxic Conditions.

The main goal of this project is to investigate how low intensity cycling exercise (1.5W/kg, for 6 minutes) influences cerebral functions, such as: Cerebral blood flow, oxygenation, and ot...

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

The purpose of this study is to observe and describe treatment patterns, like Overactive Bladder (OAB) treatment discontinuation, switching to other therapies and persistence of OAB therap...

Effect of Complementary and Alternative Medicine on Pain Among Inpatients

The proposed study has 3 aims: 1) quantitatively describe a model for delivering complementary and alternative medicine (CAM) therapies to understand the selection of patients and CAM ther...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

This is a 2‑arm, randomized, placebo-controlled, double‑blind, international, multicenter study comparing the efficacy of DCC-2618 to placebo in patients who have received treatment wi...

Companies [854 Associated Companies listed on BioPortfolio]

Baro-Therapies, Inc.

Toler RX Incorporated

TolerRx, Inc. is an emerging biopharmaceutical enterprise specializing in the discovery, development, and commercial launch of a novel class of therapies that induce and/or maintain immunological tole...

MolMed S.p.A.

Since year 2000, MolMed has evolved into a biotechnology drug-developing company, with a primary focus on novel cancer therapies. Today, MolMed is an integrated company covering all functions, from di...

BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. (www.biorestorative.com) develops products and medical procedures using cell and tissue protocols, primarily involving adult stem cells, including: ...

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompa...

More Information about "Baro-Therapies, Inc." on BioPortfolio

We have published hundreds of Baro-Therapies, Inc. news stories on BioPortfolio along with dozens of Baro-Therapies, Inc. Clinical Trials and PubMed Articles about Baro-Therapies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Baro-Therapies, Inc. Companies in our database. You can also find out about relevant Baro-Therapies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record